GlaxoSmithKline also registered Retrovir 300 mg x 60, Retrovir 250 mg x 40 and Trizivir 750 mg x 60 under the Regulation in 2004, but there were no sales under tiered prices of these products in the reporting period.
Poduzeće GlaxoSmithKline registriralo je 2004. i proizvode Retrovir 300 mg x 60, Retrovir 250 mg x 40 i Trizivir 750 mg x 60 u skladu s Uredbom, no u izvještajnom razdoblju ti se proizvodi nisu prodavali po diferenciranim cijenama.